Newsroom

News

Afficher tout

Press releases

Pherecydes Pharma successfully completes €3.1 million capital increase See more
Pherecydes Pharma launches a capital increase for c. €3m to continue its clinical development program in phage therapy See more
Pherecydes Pharma announces the enrollment of the first patient in the phase II study PhagoDAIR in the treatment of osteoarticular infections caused by Staphylococcus aureus See more

Afficher tout

Pherecydes Pharma in the media

ARTE A French documentary about Pherecydes Pharma and its products to treat burned patients (Phagoburn project)
Bacteriophages and Pherecydes Pharma in an article by PARIS MATCH see more
TELE MATIN FRANCE 2 channel broadcasted this program about Science and phagotherapy (French content)

Afficher tout

To understand phagotherapy

Media contact

For any information regarding press and media, please contact our agency:

NewCap

Nicolas Merigeau
+33 (0)1 44 71 94 98
pherecydes@newcap.eu

To stay informed of the lastest news of Pherecydes Pharma